Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24524N0645
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On June 4, 2024, the Department of Veterans Affairs, specifically Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,559.90 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg/30mg. This firm-fixed price delivery order, with an ultimate completion date of June 7, 2024, represents a procurement of specialty pharmaceutical products under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract contains no set-aside designation and will be delivered to Pittsburgh, Pennsylvania. Jynarque (tolvaptan) is a specialized medication used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring targeted pharmaceutical intervention within the VA's healthcare system.
This delivery order is issued under a larger Indefinite Delivery Vehicle held by Otsuka America Pharmaceutical Inc., specifically a Blanket Purchase Agreement valued at approximately $83.3 million awarded by the National Acquisition Center with a completion date of March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque and reflects the contractor's established capability to supply the federal healthcare system. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, is a registered federal contractor with a substantial track record of providing specialty pharmaceuticals to the VA's Veterans Health Administration through multiple contract vehicles.
Quick answers
Who was awarded contract 36C24524N0645?
36C24524N0645 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on June 4, 2024.
How much is contract 36C24524N0645 worth?
The government has obligated $12,560 on 36C24524N0645.
Is contract 36C24524N0645 an order under another contract?
Yes. 36C24524N0645 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0645 competed?
The extent of competition for 36C24524N0645 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award